ST-deviation, C-reactive protein and CPK-MB as mortality predictors in acute myocardial infarction

Mujahid Beg1, Krishna Chand Singhal, Jyoti Wadhwa

  • 1Department of Medicine, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, UP, India. muajhidbeg@rediffmail.com

Insights

Early risk stratification using C-reactive protein (CRP), CPK-MB, and ECG ST deviation can predict outcomes in acute myocardial infarction patients. These markers help differentiate between patients who improve and those with adverse events.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Prognosis in acute coronary syndromes is highly variable due to their heterogeneous nature.
  • Early risk stratification is crucial for successful management and improved patient outcomes.
  • Acute myocardial infarction (AMI) requires timely assessment to guide therapeutic decisions.

Purpose of the Study:

  • To evaluate the predictive value of C-reactive protein (CRP) and CPK-MB levels, along with electrocardiogram (ECG) ST deviation, for patient outcomes in AMI.
  • To correlate biochemical markers and ECG findings with patient prognosis following hospital admission for AMI.

Main Methods:

  • A cohort of 120 patients admitted with AMI was studied.
  • Quantitative estimation of C-reactive protein (CRP) and CPK-MB was performed at admission.
  • The number and sum of ECG leads showing ST deviation were calculated and correlated with biochemical markers.
  • Patients were divided into two groups based on final outcome: improvement or expiry.

Main Results:

  • Significant differences were observed in mean CRP and CPK-MB levels between the outcome groups.
  • The number and sum of ECG leads with ST deviation also showed significant differences between patient groups.
  • A significant correlation was found between biochemical markers and the sum of ST deviation in all AMI patients.

Conclusions:

  • CRP, CPK-MB, and ECG ST deviation are valuable indicators for risk stratification in acute myocardial infarction.
  • These early markers can help predict patient outcomes, aiding in management decisions.
  • Combined assessment of biochemical and electrocardiographic data improves prognostic accuracy in AMI.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...